Although no specific therapy for SARS-CoV-2 has been identified to date, some generic antivirals may be effective in COVID-19 treatment, such as type I interferon (IFN), a cytokine that plays an important antiviral role in innate immunity (Hung et al., 2020; Sa Ribero et al., 2020). This evidence concerns the gene IFNA1 and COVID-19.